Solazyme Announces U.S. Commercial Production of Renewable™
Algal Oils at Iowa Facilities

January 30, 2014 04:05 PM Eastern Standard Time

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Solazyme,
Inc. (NASDAQ:SZYM), a Renewable™ oil and bioproducts company,
announced today that commercial operations have commenced at both Archer
Daniels Midland Company (ADM)’s Clinton, Iowa facility, and the
downstream companion facility operated by American Natural Products in
Galva, Iowa (ANP). Highlighting the flexibility of Solazyme’s technology
platform, Solazyme, ADM and ANP have successfully manufactured three
distinct and unique TailoredTM oil products at the
facilities, and products are currently being sold and distributed in
both the U.S. and Brazil. Volumes shipped to Brazil are being utilized
for market development activity in advance of the opening of the
Solazyme Bunge Renewable Oils Moema facility. As stated previously,
production at the ADM and ANP facilities is expected to ramp to a
nameplate capacity of 20,000 MT/yr within 12-18 months, with targeted
potential expansion to 100,000 MT/yr in subsequent years.

“This is a critical milestone for Solazyme’s large scale commercial
manufacturing capabilities. The Solazyme, ADM and ANP teams have done an
excellent job bringing up commercial operations at the Iowa facilities
with Solazyme’s TailoredTM oil production technology. We have
already successfully produced three TailoredTM oil products
at scale and have begun selling these products into the North American
marketplace,” said Jonathan Wolfson, CEO Solazyme. “Consistent with our
stated plans, we are focused initially on ensuring consistent and
reliable operations as we build customer trust. While we acknowledge
that it is still early days, we look forward to the opportunity to
expand our production volume and the slate of oil products available.”

Truckloads of product are now shipping from the Iowa operations for use
in applications including lubricants, metalworking and home and personal
care. These shipments are being made pursuant to multiple supply
agreements as well as spot purchases, and include reorders.

In the high-performance lubricants and metalworking fluids industries,
Solazyme’s Renewable™ Tailored™ algal oils help to provide
outstanding performance and a sustainable solution with better
lubrication, surface tension and viscosity index, plus enhanced
stability at elevated temperature, pressure and speed. In home and
personal care, Solazyme’s Tailored™ algal oils offer better performance
and a more sustainable alternative to existing oils.

About Solazyme, Inc.

Solazyme, Inc. (SZYM)
is a Renewable™ oil and bioproducts company that transforms a
range of low-cost plant-based sugars into high-value oils. Headquartered
in South San Francisco, Solazyme's Renewable™ products can
replace or enhance oils derived from the world's three existing sources
– petroleum, plants and animal fats. Initially, Solazyme is focused on
commercializing its products into three target markets: (1) fuels and
chemicals, (2) nutrition and (3) skin and personal care.

TailoredTM, RenewableTM,
Solazyme®, and the Solazyme logo are trademarks of Solazyme, Inc.

About ADM

For more than a century, the people of Archer Daniels Midland Company
(NYSE: ADM) have transformed crops into products that serve vital needs.
Today, 30,000 ADM employees around the globe convert oilseeds, corn,
wheat and cocoa into products for food, animal feed, industrial and
energy uses. With more than 265 processing plants, 460 crop procurement
facilities, and the world’s premier crop transportation network, ADM
helps connect the harvest to the home in more than 140 countries. For
more information about ADM and its products, visit www.adm.com.

Forward Looking Statements

This press release contains certain forward-looking statements about
Solazyme, including statements that involve risks and uncertainties
concerning: the scheduled completion of manufacturing facilities; the
capacity and expandability of its manufacturing facilities and the
timetable for reaching capacity; the uses of its products; the
attributes and future performance of its products; production volume and
number of available products. When used in this press release, the words
“will”, “expects”, “intends” and other similar expressions and any other
statements that are not historical facts are intended to identify those
assertions as forward-looking statements. Any such statement may be
influenced by a variety of factors, many of which are beyond the control
of Solazyme, that could cause actual outcomes and results to be
materially different from those projected, described, expressed or
implied in this press release due to a number of risks and
uncertainties. Potential risks and uncertainties include, among others:
Solazyme’s limited operating history; its limited history in
commercializing products; implementation risk in deploying new
technologies; implementation risk in deploying its technology at ADM’s
Clinton facility; its limited experience in retrofitting, constructing
and operating commercial manufacturing facilities; market acceptance of
its products; meeting market demand; production delays related to the
ramping up and ongoing operation and optimization of production
facilities; the performance of products; its access to adequate supply
of feedstock on favorable terms; its ability to enter into and maintain
strategic collaborations; its ability to obtain requisite regulatory
approvals or permits; and its access, on favorable terms, to any
required financing. Accordingly, no assurances can be given that any of
the events anticipated by the forward-looking statements will transpire
or occur, or if any of them do so, what impact they will have on the
results of operations or financial condition of Solazyme.

In addition, please refer to the documents that Solazyme, Inc. files
with the Securities and Exchange Commission, including its Quarterly
Reports on Form 10-Q for a discussion of these and other risks. You are
cautioned not to place undue reliance on forward-looking statements,
which speak only as of the date of this press release. Solazyme is not
under any duty to update any of the information in this press release.